Cargando…

Development of cancer-associated fibroblast-related gene signature for predicting the survival and immunotherapy response in lung adenocarcinoma

The present study aims to construct a predictive model for prognosis and immunotherapy response in lung adenocarcinoma (LUAD). Transcriptome data were extracted from the Cancer Genome Atlas (TCGA), GSE41271, and IMvigor210. The weighted gene correlation network analysis was utilized to identify the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yong, Cheng, Fuyi, Ma, Jinhu, Shi, Gang, Deng, Hongxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292873/ https://www.ncbi.nlm.nih.gov/pubmed/37280069 http://dx.doi.org/10.18632/aging.204774

Ejemplares similares

A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
por: Zhu, Kaibin, et al.
Publicado: (2022)

A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts
por: Ren, Qianhe, et al.
Publicado: (2023)

An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma
por: Yang, Chuang, et al.
Publicado: (2023)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma
por: Zhang, Minghui, et al.
Publicado: (2019)

An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma
por: Wu, Yuxin, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy
por: Sun, Zhiqiang, et al.
Publicado: (2022)

Tumor microenvironment related novel signature predict lung adenocarcinoma survival
por: Chen, Juan, et al.
Publicado: (2021)

Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
por: Sun, Zihao, et al.
Publicado: (2023)

Identification of a polycomb group-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Liu, Lei, et al.
Publicado: (2023)

A Novel Mitochondrial-Related Nuclear Gene Signature Predicts Overall Survival of Lung Adenocarcinoma Patients
por: Zhang, Xiangwei, et al.
Publicado: (2021)

A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma
por: Liang, Jin-xiao, et al.
Publicado: (2022)

An expression signature model to predict lung adenocarcinoma-specific survival
por: Shi, Xiaoshun, et al.
Publicado: (2018)

EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma
por: Chen, Zhiming, et al.
Publicado: (2020)

Identification of an Exosome-Related Signature for Predicting Prognosis, Immunotherapy Efficacy, and Tumor Microenvironment in Lung Adenocarcinoma
por: Lin, Tao, et al.
Publicado: (2022)

A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Tang, Xiaolong, et al.
Publicado: (2022)

Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma
por: Li, Zhouhua, et al.
Publicado: (2022)

A novel methionine metabolism-related signature predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Qing-Hua, et al.
Publicado: (2023)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

Cancer-associated fibroblast-related prognostic signature predicts prognosis and immunotherapy response in pancreatic adenocarcinoma based on single-cell and bulk RNA-sequencing
por: Chen, Yajun, et al.
Publicado: (2023)

Prognostic necroptosis-related gene signature aids immunotherapy in lung adenocarcinoma
por: Song, Yuqi, et al.
Publicado: (2022)

Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2023)

APOBEC mutational signature predicts prognosis and immunotherapy response in nonsmoking patients with lung adenocarcinoma
por: Ma, Jianli, et al.
Publicado: (2023)

A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma
por: Nguyen, Thinh T., et al.
Publicado: (2022)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
por: Li, Xizhe, et al.
Publicado: (2022)

A Novel Signature of Lipid Metabolism-Related Gene Predicts Prognosis and Response to Immunotherapy in Lung Adenocarcinoma
por: Zhang, Kai, et al.
Publicado: (2022)

A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2023)

Identification and validation of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with lung adenocarcinoma
por: Li, Chunhong, et al.
Publicado: (2023)

A novel necroptosis signature for predicting survival in lung adenocarcinoma
por: Zang, Kui, et al.
Publicado: (2023)

Deciphering N(6)-Methyladenosine-Related Genes Signature to Predict Survival in Lung Adenocarcinoma
por: Zhu, Jie, et al.
Publicado: (2020)

Identification of a Pyroptosis-Related Gene Signature for Prediction of Overall Survival in Lung Adenocarcinoma
por: Dong, Zheng, et al.
Publicado: (2021)

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
por: Huang, Jihong, et al.
Publicado: (2022)

Constructing an APOBEC-related gene signature with predictive value in the overall survival and therapeutic sensitivity in lung adenocarcinoma
por: Luo, Yu, et al.
Publicado: (2023)

Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma
por: Duan, Jin, et al.
Publicado: (2021)

A network-based signature to predict the survival of non-smoking lung adenocarcinoma
por: Mao, Qixing, et al.
Publicado: (2018)

Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma
por: Yu, Qian, et al.
Publicado: (2022)

Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
por: Cui, Yingshu, et al.
Publicado: (2023)

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023)

Construction of a Novel Ferroptosis-Related Gene Signature for Predicting Survival of Patients With Lung Adenocarcinoma
por: Song, Xiaojie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ku0lm959dnofas5ovc89f571m9